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INTRODUCTION
Selenocysteine (Sec) is inserted into proteins when 
UGA (normally a stop codon) is recoded to serve as Sec 
codon.[1,2] This amino acid is typically found at the cat-
alytic sites of oxidoreductase selenoproteins and is re-
sponsible for the high catalytic activity of selenoenzymes 
when compared with their cysteine (Cys)-containing ho-
mologs.[3-6] Selenoproteins are found in all three do-
mains of life: bacteria, archaea, and eukaryotes. The 
glycine reductase A from Clostridium sticklandii was dis-
covered as the first anaerobic selenoprotein.[7,8] A com-
plex machinery is required for translational insertion of 
Sec in response to UGA codon.[2,9,10] A stem-loop struc-
ture in selenoprotein mRNAs, called SECIS (Sec insertion 
sequence) element, is essential for Sec insertion in both 
prokaryotes and eukaryotes. SECIS elements are located 
immediately downstream of Sec-encoding UGA codons 
in bacteria, whereas they are present in the 3′-untransla-
tional regions in archaea and eukaryotes. In addition to 
this cis-acting factor, several trans-acting factors, such as 
Sec-specific elongation factor and tRNASec, are required 
for Sec incorporation.
There has been significant progress recently in identi-
fying selenoprotein genes in organisms from bacteria to 
mammals owing to both a dramatic increase in genomic 
sequence information and the development of bioin-
formatics methods that allow searches for selenopro-
tein genes.[11-16] These methods include searches for 
(1) SECIS elements; and (2) Sec/Cys pairs in predicted 
homologs.
Methionine residues are easily oxidized by various re-
active oxygen species to methionine sulfoxides; however, 
the oxidized methionines can be reduced back to methio-
Published in Proteins: Structure, Function, and Bioinformatics 74:4 (2009), pp. 1008-1017; doi 10.1002/prot.22212 Copyright © 2009 
Wiley-Liss, Inc., A Wiley Company. Used by permission. http://www3.interscience.wiley.com/journal/36176/home 
Research reported in this article was funded by Korea Science and Engineering Foundation (KOSEF); Grant Number: R13-2005-
005-01004-0; National Institutes of Health (NIH); Grant Number: AG021518; and The Yeungnam University Research Grant.
Submitted May 6, 2008; revised June 18, 2008; accepted June 29, 2008; published online September 2, 2008.
The selenoproteome of Clostridium sp. OhILAs:  
Characterization of anaerobic bacterial selenoprotein  
methionine sulfoxide reductase A
Hwa-Young Kim, 1 Yan Zhang, 2 Byung Cheon Lee, 2 Jae-Ryong Kim, 1 Vadim N. Gladyshev 2
1Department of Biochemistry and Molecular Biology, Aging-associated Vascular Disease Research Center, Yeungnam University 
College of Medicine, Daegu 705-717, Republic of Korea 
2Department of Biochemistry and Redox Biology Center, University of Nebraska, Lincoln, Nebraska 68588
Correspondence — Hwa-Young Kim, Department of Biochemistry and Molecular Biology, Yeungnam University College of Medi-
cine, 317-1 Daemyung-dong, Namgu, Daegu 705-717, South Korea; email hykim@ynu.ac.kr 
Abstract
Selenocysteine (Sec) is incorporated into proteins in response to UGA codons. This residue is frequently found at the catalytic sites 
of oxidoreductases. In this study, we characterized the selenoproteome of an anaerobic bacterium, Clostridium sp. (also known as 
Alkaliphilus oremlandii) OhILA, and identified 13 selenoprotein genes, five of which have not been previously described. One of 
the detected selenoproteins was methionine sulfoxide reductase A (MsrA), an antioxidant enzyme that repairs oxidatively dam-
aged methionines in a stereospecific manner. To date, little is known about MsrA from anaerobes. We characterized this seleno-
protein MsrA which had a single Sec residue at the catalytic site but no cysteine (Cys) residues in the protein sequence. Its SECIS 
(Sec insertion sequence) element did not resemble those in Escherichia coli. Although with low translational efficiency, the expres-
sion of the Clostridium selenoprotein msrA gene in E. coli could be demonstrated by 75Se metabolic labeling, immunoblot anal-
yses, and enzyme assays, indicating that its SECIS element was recognized by the E. coli Sec insertion machinery. We found that 
the Sec-containing MsrA exhibited at least a 20-fold higher activity than its Cys mutant form, indicating a critical role of Sec in the 
catalytic activity of the enzyme. Furthermore, our data revealed that the Clostridium MsrA was inefficiently reducible by thiore-
doxin, which is a typical reducing agent for MsrA, suggesting the use of alternative electron donors in this anaerobic bacterium 
that directly act on the selenenic acid intermediate and do not require resolving Cys residues. 
Keywords:  MsrA, selenoproteins, oxidoreductase, SECIS elements, thioredoxin
Abbreviations: DTT, dithiothreitol; Msr, methionine sulfoxide reductase; Sec, selenocysteine; SECIS, selenocysteine insertion se-
quence; Trx, thioredoxin.
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nine by repair enzymes, the methionine sulfoxide reduc-
tases (Msrs).[17] Two distinct families of these enzymes, 
MsrA and MsrB, have evolved for stereospecific reduction 
of methionine sulfoxide residues in proteins. MsrA is spe-
cific for the reduction of the S-form of methionine sulfox-
ide, whereas MsrB is specific for the R-form. Msrs are pres-
ent in most organisms in all three domains of life (they 
have been even found in anaerobic bacteria), but are absent 
in some hyperthermophiles and parasites.[18,19] Msrs play 
a pivotal role in the repair of oxidatively damaged proteins 
and defend cells from oxidative stress. Therefore, these 
proteins are viewed as protein repair and antioxidant en-
zymes.[20-22] These enzymes have been implicated in reg-
ulation of physiological and pathological processes such as 
aging and neurodegenerative diseases.[23,24]
In this study, we characterized the selenoproteome 
of an anaerobic gram-positive bacterium, Clostridium sp. 
(also known as Alkaliphilus oremlandii) OhILAs and found 
that this bacterium is predicted to be rich in selenopro-
teins and contains at least 13 selenoproteins, including 
MsrA. We further experimentally characterized Clostrid-
ium selenoprotein MsrA. We found that its SECIS element 
is recognized by the Escherichia coli Sec insertion machin-
ery, and that Sec plays a critical role in the catalytic activ-
ity of this selenoprotein.
METHODS
Identification of selenoprotein genes in Clostridium sp. 
OhILAs
The complete genome of Clostridium sp. OhILAs (NC_
009922) was downloaded from the NCBI ftp server 
(ftp://ftp.ncbi.nih.gov/genomes/Bacteria/). We used 
bSECISearch program developed previously[15] to search 
this genome for all candidate selenoprotein sequences 
containing in-frame UGA codons and bacterial SECIS 
(bSECIS) elements. The resulting dataset was then di-
vided into homologs of previously known selenoproteins 
and selenoprotein candidates. All candidates were man-
ually analyzed for the location of the UGA codon, occur-
rence of Sec- and Cys-containing homologs in Sec-utiliz-
ing or other organisms, and presence of SECIS elements in 
Sec-containing homologs. In parallel, independent BLAST 
homology searches for Sec-containing homologs of all 
known selenoprotein families were performed using de-
fault parameters. Finally, both known and candidate sele-
noprotein sets were generated. Multiple sequence align-
ments were performed using ClustalW program[25] with 
default parameters and visualized with BoxShade pro-
gram v3.21.
Cloning, expression, and purification of wild-type seleno-
protein and its Cys mutant of Clostridium MsrA
A coding region of the selenoprotein msrA gene was 
amplified by PCR using Clostridium sp. OhILAs genomic 
DNA (kindly provided from Dr. John Stolz, Duquesne 
University, Pittsburgh, USA) and cloned into NdeI/XhoI 
sites of pET21b (Novagen). To amplify the gene, forward 
(5′-GCGCCATATGGATACCAATCAGAAGTTG-3′) 
and reverse (5′-CGCGCTCGAGTTTAATTTCTTCGAC-
GATAG-3′) primers were used. The resulting construct, 
designated pET-CLOS-MsrA, coded for full-length sele-
noprotein MsrA with a C-terminal His-tag (LEHHH-
HHH). A SECIS element was found to be located immedi-
ately downstream of the Sec UGA codon (see Figure 4). A 
Cys mutant form was also generated in which Sec16 was 
replaced with Cys by site-directed mutagenesis. The re-
sulting construct was named pET-CLOS-MsrA/U16C.
To express selenoprotein MsrA in E. coli, the plasmid 
pET-CLOS-MsrA was transformed into BL21(DE3) cells 
that also harbored a plasmid pSUABC,[26] which encodes 
E. coli selA, selB, and selC. The transformed cells were 
grown in LB media containing 4 μM sodium selenite, 100 
μg/mL ampicillin, and 25 μg/mL chloramphenicol at 
37°C with shaking until optical density at 600 nm reached 
0.6-0.8; then 0.2 mM IPTG was added and the cells were 
further cultured for 4 h at 30°C, harvested, and stored at 
-20°C until use. A typical expression level of the seleno-
protein MsrA was 0.6 μg/mg crude protein.
The cell pellets were resuspended in the extrac-
tion buffer (50 mM sodium phosphate, pH 7.0, 300 mM 
NaCl, 10 mM imidazole, and 1 mM phenylmethylsul-
fonyl fluoride) and lysed by sonication. The selenopro-
tein MsrA was further purified using a Talon-metal af-
finity resin (Clontech) according to the manufacturer’s 
protocol. The eluted proteins were dialyzed against 50 
mM sodium phosphate, pH 7.5, and 50 mM NaCl. Typ-
ical yield of the purified selenoprotein MsrA was 3-5 μg 
from 250 mL culture broth, as estimated by Western blot 
assays. Although the protein was not pure, this prepa-
ration was sufficient to determine kinetic parameters of 
the enzyme.
To express the Cys mutant form (U16C), BL21(DE3) 
cells transformed with pET-CLOS-MsrA/U16C were cul-
tivated in LB media containing 100 μg/mL ampicillin at 
37°C with shaking until optical density at 600 nm reached 
0.6-0.8, 0.1 mM IPTG was added, and the cells were fur-
ther cultured for 6 h at 30°C. The cells were harvested and 
stored at -20°C until use. Procedures for purification of 
this protein were as described earlier for the selenopro-
tein form. The purity of the Cys mutant protein was ana-
lyzed by SDS-PAGE and found to exceed 95%.
Metabolic labeling with 75Se
To prepare cells expressing Clostridium selenoprotein 
MsrA with metabolically labeled 75Se, E. coli BL21(DE3) 
cells were transformed with pET-CLOS-MsrA and grown 
at 37°C in 5 mL LB media containing ampicillin until op-
tical density at 600 nm reached ~0.6. Then, 0.05 mCi of 
freshly neutralized [75Se]selenous acid (specific activity 
1000 Ci/mmol, University of Missouri Research Reactor, 
1010 h-Y. KI m e T A l. I n Pr ot ei n s  74 (2009) 
Columbia, USA) was added to the cell culture with 1 mM 
IPTG for induction. The cells were further grown at 37°C 
for 5 h, harvested, washed with PBS buffer, and lysed. 
Cell extracts (40 μg of total protein) were applied to a 10% 
Bis-Tris gel (Invitrogen), electrophoresed, and transferred 
onto a PVDF membrane. The 75Se radioactivity pattern on 
the membrane was visualized by using a PhosphorIm-
ager (GE Health Care).
Determination of protein concentration
Concentration of recombinant selenoprotein MsrA was 
determined by western blotting using His antibodies and 
Cys mutant as an internal standard, followed by quan-
tifying the blot signals with a densitometer. Concentra-
tion of purified Cys mutant was determined by Bradford 
method using a Bio-Rad protein assay reagent (Bio-Rad) 
and bovine serum albumin as a standard.
MsrA enzyme assay and analysis of kinetics
MsrA activity was measured in the presence of dithio-
threitol (DTT) or thioredoxin (Trx) as a reducing agent. 
In the DTT-dependent reaction, reaction mixture (100 
μL) contained 50 mM sodium phosphate, pH 7.5, 50 mM 
NaCl, 20 mM DTT, 200 μM DABSyl-methionine-S-sulf-
oxide, and purified (or crude) proteins. In the Trx-depen-
dent reaction, the reaction mixture (100 μL) contained 50 
mM sodium phosphate, pH 7.5, 50 mM NaCl, 0.2 mM 
NADPH, 6.8 μM E. coli Trx (Sigma) or human Trx1,[27] 
0.8 μM human Trx reductase 1,[27] 200 μM DABSyl-me-
thionine-S-sulfoxide, and purified proteins. The reac-
tions were carried out at 37°C for 30 min and analyzed 
by HPLC as described previously.[28] A full-length 
mouse MsrA was purified from E. coli as described previ-
ously[29] and used for comparison.
Km and kcat values were determined from Lineweaver-
Burk plots using 50-400 μM substrate in the DTT- depen-
dent reaction.
RESULTS AND DISCUSSION
Clostridium sp. OhILAs is a selenoprotein-rich organism
By searching the Clostridium sp. OhILAs genome 
against a set of all known selenoprotein genes, we iden-
tified eight selenoproteins in Clostridium sp. OhILAs, in-
cluding formate dehydrogenase alpha subunit (FdhA), 
which is the most widespread prokaryotic selenopro-
tein that appears to be responsible for maintaining the 
Sec utilization trait in sequenced bacteria,[30] and sele-
nophosphate synthetase (SelD), another widespread sele-
noprotein which is a key component in prokaryotic sele-
noprotein biosynthesis. Other detected selenoproteins 
included proline reductase, HesB-like protein, glutare-
doxin, glycine reductase selenoproteins A (GrdA) and B 
(GrdB), and MsrA. Previously, selenoprotein MsrA has 
only been characterized in a eukaryotic organism, Chlam-
ydomonas reinhardtii.[31][32] The selenoproteome of Clos-
tridium sp. OhILAs is shown in Table I and all detected 
selenoprotein sequences are included in the supporting 
sequence data. 
Next, we used bSECISearch to analyze Clostridium sp. 
OhILAs for full complement of selenoprotein genes. In 
addition to the eight homologs of known selenoproteins, 
we detected five new selenoproteins that represented four 
protein families (Table I). The mRNAs of all new seleno-
proteins contained predicted stable stem-loop structures 
downstream of Sec-encoding UGA codons that shared 
common features of bacterial SECIS elements,[15] i.e. a 
stable stem with a small apical loop containing a G nucle-
otide located at a certain distance from the Sec UGA co-
Table I. Known and New Selenoproteins Detected in Clostridium sp. OhILAs
                                                                                                                                                                                        Sec position
Protein family                       Accession no.            COG/Pfam         Occurrence  (protein length)
Known selenoproteins
  FdhAa YP_001513778 COG3383 1 349 (891)
  SelDa YP_001513274 COG0709 1 16 (346)
  MsrAa YP_001513481 COG0225 1 16 (209)
  Proline reductasea YP_001511596 pfam07355 (low homology) 1 151 (241)
  HesB-like YP_001511838 (partial sequence) COG0316 1 32 (95)
  Glutaredoxina YP_001513661 COG0695 1 13 (76)
  GrdAa YP_001512500 pfam04723 1 44 (158)
  GrdBa YP_001512501 pfam07355 1 350 (435)
New selenoprotein candidates
  Putative anaerobic dehydrogenasea YP_001511765 COG0243 1 257 (1021)
  BFD-like (2Fe-2S)-binding domain protein YP_001512630 (partial sequence) COG2906 (low homology) 1 11 (162)
  Split soret cytochrome c precursora YP_001512574; YP_001512575 pfam09719 (low homology) 2 83 (223)  
    81 (221)
  Predicted NADH:ubiquinone YP_001511593 (partial sequence) COG4656 1 389 (424)
        oxidoreductase, subunit RnfC
 a Annotated as selenoproteins in the current genome annotation.
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don (see Figure 1). No additional common features could 
be found in those Clostridium SECIS elements and all of 
them were predicted to lack a bulged U which is con-
served in E. coli SECIS elements. Selenoprotein homo-
logs of the new selenoproteins were also found in several 
other anaerobic bacteria, such as Desulfitobacterium hafni-
ense, Alkaliphilus metalliredigens, and Clostridium botulinum 
(see Figure 2). In addition, conserved Cys-containing ho-
mologs could be detected for all new selenoproteins in 
other organisms. Multiple alignments of new selenopro-
tein families and their Cys homologs are shown in Figure 
2 and highlight conserved Sec/Cys pairs in homologous 
sequences that support predicted redox functions of these 
proteins.[33] 
Although the functions of new selenoproteins are not 
clear, they either contained a domain of known function 
or were homologous to protein families with known func-
tions. However, in some of them Sec was not part of the 
detected domains, suggesting the presence of functional 
redox-active sites in the locations outside of known do-
mains. For example, Sec was located in the N-terminal re-
gion of BFD-like (2Fe-2S)-binding protein in which the 
BFD-like domain (COG2906) was present in the C-termi-
nal region. It was also found in a CxxU (x, any amino acid 
residue; U, Sec) redox motif in the C-terminal region of 
a predicted NADH:ubiquinone oxidoreductase subunit 
RnfC, whereas the known RnfC domain (COG4656) was 
located in the N-terminal region. The other three new sele-
noproteins (putative anaerobic dehydrogenase and two 
cytochrome c precursor sequences) were annotated as pu-
tative selenoproteins in this genome although the criteria 
used in their detection/annotation are not clear. As these 
sequences have passed the stringent criteria employed by 
bSECISearch in our study, they should be viewed as ex-
cellent candidate selenoproteins.
While this study was prepared for publication, the se-
quences of three new selenoproteins were released at 
GenBank database (putative anaerobic dehydrogenase, 
158139457; split soret cytochrome c precursor 1, 158320067; 
split soret cytochrome c precursor 2, 158320068). It is in-
teresting that the Sec positions differed in the predicted 
NADH:ubiquinone oxidoreductase subunit RnfC fam-
ily between Clostridium sp. OhILAs and several strains of 
Clostridium botulinum (see Figure 2). Taken together, our 
data suggested that novel Se-dependent pathways are 
present in this selenoprotein-rich organism. Further ex-
perimental verification is needed for the newly identified 
selenoproteins.
Clostridium selenoprotein MsrA sequence
Msr genes have been found in most organisms, even 
in anaerobes. The presence of Msr genes in anaerobic bac-
teria may be due to their roles in protein repair and anti-
oxidant defense when transiently exposed to oxygen. To 
date, little is known about such anaerobe-based Msrs. We 
selected the anaerobic bacterial selenoprotein MsrA for 
further experimental examination. Interestingly, sequence 
context revealed lack of any Cys residues in this protein. 
Because Sec corresponded to the catalytic residue, this ob-
servation suggested the lack of resolving residues dur-
ing catalysis (see Figure 3). The catalytic mechanism of 
Figure 1. Predicted bacterial SECIS elements in new selenoprotein genes. Only sequences downstream of in-frame UGA codons 
are shown. In-frame UGA codons and functionally important G nucleotides in the apical loop are shown in red.
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Cys-containing MsrA is well characterized and involves a 
sulfenic acid intermediate.[34-36] During the reaction, the 
catalytic Cys attacks the sulfoxide moiety of methionine 
sulfoxide resulting in sulfenic acid on this residue with 
a concomitant release of the product, methionine. Then, 
the sulfenic acid intermediate is rearranged into a disul-
fide bond by reacting with another Cys, known as resolv-
ing (or recycling) Cys, and finally the disulfide bond is re-
duced by a two-electron reductant. Trx is typically an in 
vivo reducing agent while DTT can be used in the in vitro 
assays. In the case of Sec-containing forms, the selenenic 
acid intermediate may form a selenenylsulfide bond with 
a resolving Cys; however, neither of the previously iden-
tified selenoprotein MsrAs possesses conserved Cys that 
could function as resolving residues.[31] Furthermore, we 
previously reported that Chlamydomonas selenoprotein 
MsrA does not use resolving Cys.[31] 
Expression of Clostridium selenoprotein MsrA in E. coli
The mechanism of Sec insertion has been well eluci-
dated in E. coli.[3,37-39] The SECIS element in mRNA 
is essential for Sec insertion and is located immediately 
Figure 2. Multiple sequence alignments of new selenoproteins and their Cys homologs. The alignments show Sec-flanking regions 
in detected selenoproteins. Both selenoprotein sequences detected in Clostridium sp. OhILAs and their Sec/Cys-containing homo-
logs that occur in the indicated organisms are shown. Conserved residues are highlighted. Predicted Sec (U) and the correspond-
ing Cys (C) residues in other homologs are shown in red and blue, respectively.
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downstream of in-frame UGA codons in bacteria. Stud-
ies on E. coli SECIS elements revealed that only a minimal 
stem-loop is required for Sec insertion in which a GU se-
quence on the tip of the apical loop and a bulged U pres-
ent at the bottom of the stem are essential for Sec insertion 
(Figure 4, left).[40-42] We recently reported a consensus 
bacterial SECIS structural model in which a conserved G 
is present in the apical loop, whereas the bulged U is an 
E. coli adaptation that is missing in most other bacterial 
SECIS elements.[15] Consistent with this consensus, the 
SECIS element of Clostridium msrA had a G in the apical 
loop, but not the bulged U in the stem (Figure 4, right). 
The differences between E. coli SECIS elements and the 
corresponding structures in other bacteria result in barri-
ers in heterologous selenoprotein expression.[43] 
To test whether Clostridium selenoprotein MsrA can 
be expressed in E. coli as recombinant protein, we meta-
bolically labeled cells transformed with Clostridium msrA 
gene with 75Se. As shown in Figure 5(A), a 25 kDa radio-
active band corresponding in size to the calculated mo-
lecular weight of recombinant Clostridium selenoprotein 
MsrA, was detected. We also verified the expression of 
this protein by western blot analysis [Figure 5(B)]. In ad-
dition, enzyme assays revealed that crude extracts from 
cells expressing the Clostridium msrA gene had a 36-fold 
increased activity compared with that from cells con-
taining an empty vector [Figure 5(C)]. Thus, these data 
showed that Clostridium selenoprotein msrA could be ex-
pressed in E. coli, indicating that its SECIS element is rec-
ognized by the E. coli Sec insertion machinery. To estimate 
the efficiency in Sec insertion (UGA readthrough), we an-
alyzed the amounts of wild-type and Cys mutant (U16C) 
forms of the enzyme in crude extracts by Western blotting 
using the purified U16C as an internal standard. It should 
be noted that most of U16C protein (>95%) expressed in 
BL21(DE3) cells was present in the soluble fraction. The 
yields of the wild-type selenoprotein and the U16C mu-
tant were 0.6 and 380 μg/mg crude protein, respectively. 
Therefore, the translational efficiency of the selenoprotein 
MsrA was low, estimated to be 0.15% of that of its Cys 
Figure 3. Multiple sequence alignment of MsrAs. Sec (U) residues are highlighted in red in the catalytic GUFW(G/H) motif and the 
corresponding Cys residues are highlighted in blue. The known resolving Cys residues in the C-terminal region are highlighted in 
pink. Genbank accession numbers are as follows: Clostridium sp. OhILAs, 106894182; Chlamydomonas reinhardtii, 23452038; Syntro-
phobacter fumaroxidans, 71547479; E. coli, 1790665; Mus musculus, 31981013; Drosophila melanogaster, 23338220.
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variant. The activities of the wild-type selenoprotein and 
Cys mutant forms in the crude extracts as shown in Fig-
ure 5(C) agreed well with those of the purified forms, re-
spectively (Table II). 
There have been several reports on heterologous ex-
pression of eukaryotic selenoproteins in E. coli.[6,26,44,45] 
Either the entire SECIS element of E. coli fdhH (in most 
studies) or a minimal SECIS stem-loop had to be intro-
duced downstream of UGA codon to express eukary-
otic selenoproteins. In E. coli, heterologous expression of 
bacterial selenoproteins that contain their own SECIS el-
ements often fails due to SECIS structure barriers.[46] 
However, a few successful cases have been previously re-
ported.[47,48] In our study, irrespective of discrepancies 
in Clostridium msrA and E. coli SECIS elements, the Clos-
tridium selenoprotein msrA gene could be expressed in E. 
coli. However, as discussed earlier, the translational ef-
ficiency was low (less than 0.2% compared with its Cys 
variant) even when the cells were co-expressed with 
selA, selB, and selC genes encoding selenocysteine syn-
thase, SelB and tRNASec, respectively. These results sug-
gest a low functionality of the SECIS element of Clostrid-
ium msrA in the E. coli Sec insertion system.
Characterization of Clostridium selenoprotein MsrA
To investigate catalytic properties of Clostridium MsrA, 
we purified this protein (tagged at the C-terminus with 
His) from E. coli cells. As shown in Table II, the specific 
Figure 5. Expression of Clostridium selenoprotein MsrA in E. coli. (A) 75Se metabolic labeling. BL21(DE3) cells transformed with an 
empty vector (lane 1) or pET-CLOS-MsrA (lane 2) were metabolically labeled with 75Se. Proteins were separated by SDS-PAGE, 
transferred onto a PVDF membrane, and visualized with a PhosphorImager. (B) Western blot analysis. Purified Cys mutant 
(U16C) and crude extracts from cells expressing Clostridium selenoprotein MsrA were analyzed using anti-His antibodies. Lane 1, 
purified U16C; lane 2, wild-type selenoprotein MsrA from cell extracts. (C) Enzyme assays. Crude extracts from cells containing 
an empty vector, pET-CLOS-MsrA (wild-type), or pET-CLOS-MsrA/U16C (U16C mutant) were prepared, respectively. A total of 
200μg crude protein from control and CLOS-MsrA extracts and 2 μg crude protein of the CLOS-MsrA/U16C extract were used in 
a DTT-dependent assay in the presence of 200 μM DABSyl-methionine-S-sulfoxide
Figure 4. Structures of SECIS elements in E. coli fdhH (left) 
and Clostridium sp. OhILAs msrA (right). In the E. coli fdhH 
SECIS element, the minimal step-loop structure is boxed and 
the bulged U is shown in italics. The Clostridium msrA SECIS 
element lacks the bulged U. Conserved G in the apical loops 
is shown in red in both SECIS elements. Sec UGA codons are 
shown in blue.
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activity of Clostridium selenoprotein MsrA was found to 
be 4185 nmol/(min mg protein) in a DTT-dependent re-
action. This value was 9-fold higher than that of its Cys 
mutant (U16C). The kcat value of the selenoprotein MsrA 
was 22-fold higher than that of its Cys mutant and the Km 
value of the selenoprotein was 2.5-fold higher. Overall, 
these data show that selenium provides catalytic advan-
tage to Clostridium MsrA. Importantly, this enzyme ap-
pears to be a highly efficient catalyst with kinetic prop-
erties comparable with those of Chlamydomonas MsrA 
characterized previously.[31]
Trx is typically a natural reductant for MsrA. To test if 
Trx can function as a reductant for Clostridium MsrA, we 
measured Trx-dependent activities of its natural Sec-con-
taining and mutant Cys-containing forms using human 
Trx1 and Trx reductase 1, and compared the data with the 
DTT-dependent activities of these MsrA forms. In addi-
tion, mouse MsrA served as control because this protein is 
known as a target of Trx. As shown in Table III, the ratio 
of Trx- to DTT-dependent activities of mouse MsrA was 
0.73, indicating that human Trx1 as well as DTT could ef-
ficiently reduce this protein. However, for Clostridium 
selenoprotein MsrA, this ratio was less than 0.01, suggest-
ing that Trx1 was a poor reductant for this selenoprotein. 
Similarly, the Cys mutant could not be efficiently reduced 
by Trx1 (the ratio of Trx- to DTT-dependent activity was 
0.03). To examine the possibility that human Trx couples 
poorly to the bacterial selenoprotein MsrA, we carried out 
the enzyme assay in the presence of bacterial (E. coli) Trx. 
The ratios of Trx- to DTT-dependent activities were con-
sistent with the results for human Trx1; 0.93 for mouse 
MsrA, 0.016 for Clostridium selenoprotein MsrA, and 0.05 
for its Cys mutant. Therefore, our data suggested that Trx 
is not a reducing agent in vivo for Clostridium MsrA and 
that unknown physiological reductant(s) must function in 
the reduction of this enzyme. 
Recent studies revealed that thionein (a low-molec-
ular-mass Cys-rich protein) can function as a reducing 
agent for MsrA and MsrB,[49] and that selenium com-
pounds such as selenocysteamine could reduce mam-
malian MsrBs.[50] Our previous study on Chlamydomo-
nas selenoprotein MsrA and its Cys mutant revealed that 
the Trx-dependent activities of these enzyme forms were 
more than 20-fold lower than their DTT-dependent activ-
ities.[31] Taken together and combined with the obser-
vation that known selenoprotein MsrAs lack conserved 
resolving Cys residues (or do not have any Cys as in Clos-
tridium MsrA),[31] our data on Chlamydomonas and Clos-
tridium MsrAs suggest that Trx is not a natural reducing 
agent for the selenenic acid intermediates of selenopro-
tein MsrAs.
CONCLUSIONS
This study shows that Clostridium sp. OhILAs, a gram-
positive anaerobic bacterium, is predicted to be a sele-
noprotein-rich organism that contains 13 selenoproteins, 
including five that have not been previously described. In-
terestingly, one of the detected selenoproteins was MsrA, 
which serves an antioxidant function by catalyzing the re-
duction of methionine-S-sulfoxide. Little is known about 
anaerobic bacterial MsrAs. We cloned and expressed this 
Clostridium selenoprotein in E. coli. Although its SECIS el-
ement did not resemble those in E. coli, we could verify 
the recombinant protein expression by 75Se labeling, west-
ern blots, and activity assays. Thus, the SECIS element 
of Clostridium selenoprotein msrA is functional and rec-
ognized by the E. coli Sec insertion machinery, although 
the translational efficiency was found to be low. The en-
zyme assays and kinetic analyses revealed that the sele-
noprotein MsrA is much more active than its Cys mutant 
form, indicating a key contribution of selenium to the cat-
alytic efficiency of this selenoenzyme. Our data also sug-
gest that Trx, a general in vivo reducing agent for MsrA, is 
not a reductant for Clostridium selenoprotein MsrA. Fur-
ther studies will be needed to characterize the detailed re-
ductase steps including determination of the natural re-
ducing agent for this selenoprotein MsrA.
Table II. Specific Activity and Kinetic Constants of Clostridium 
MsrA Forms
                       Specific
MsrA        activity [nmol/              Km                  kcat         kcat/Km 
form       (min mg protein)]           (mM)              (s-1)           (M-1 s-1)
WT 4185 ± 46 10.2 ± 1.2 84 ± 5 8235
U16C 464 ± 14 4.0 ± 0.2 3.8 ± 0.3 950
Purified proteins (90 ng WT and 1 μg U16C) were assayed in the DTT-
dependent reaction. The substrate (DABSyl-methionine-S-sulfoxide) 
concentration used was 200 μM for the determination of specific activ-
ity. Km and kcat values were determined from Lineweaver-Burk plots 
using 50-400 μM substrate in the presence of DTT. WT, wild-type sele-
noprotein; U16C, Sec to Cys mutant.
Table III. Ratios of Trx- to DTT-Dependent Activities
                                          Specific activity  
                                       [nmol/(min mg protein)]
                                                                                                      Ratio of  
                                                           Trx-dependent                Trx/DTT  
                                                                   reaction                      activity
                          DTT-dependent   
MsrA form                  reaction        hTrx1          eTrx         hTrx1      eTrx
WT 4185 ± 46 34 ± 5 70 ± 6 0.008 0.017
U16C 464 ± 14 14 ± 2 23 ± 2 0.03 0.05
Mouse MsrA 256 ± 24 188 ± 9 238 ± 8 0.73 0.93
Purified proteins (90 ng WT, 1 μg U16C, and 1 μg mouse MsrA) were 
used in the DTT- and Trx-dependent assays containing 200 μM DAB-
Syl-methionine-S-sulfoxide. hTrx1, human cytosolic Trx; eTrx, E. coli 
Trx; WT, Clostridium selenoprotein MsrA; U16C, its Cys mutant.
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Supplementary Sequence Data 
 
>FdhA 
MAKIMINGESYEVKNDITILQACREIGIEIPTLCHDDRLEPHAACRLCIVEIEGVRNLSTSCTMKVAEGM
NIQTHSKNVMNTRKELLDLLFSNHPNDCLTCEKSGECKLQDYCYEYGVLGGSYKGEKRNLPIDYSNHFYT
YDPNKCILCGKCVRVCSELQCTNAITIDERGFHTSIATPFRKGLEHSTCVSCGNCVAVCPVGALTPKKRQ
KVRAWETKKVKTTCSYCGVGCQLNLIVHEDKVIGAEPGRGVPNDGLLCVKGRFANAFINHEERLKTPLIR
KNGVLEEATWDEALGLIVSKVQSTKEKHGANALGGFSSARCTNEENYLFQKLFRAVIGTNNVDHCARLUH
SATVAGLATTLGSGAMTNSIGEVVNNDLLFITGTNTTENHPVIGTQVKQAKKKGAKLIVADPRRIELADM
ADVYLQIKPGTNIALMNGMLNYIIENDLHDKAYIEERTENFEDVKETVKAYTLERTAQICGVAPEDIAKA
ARMYAASDRAGIYYAMGITQHTTGTHNVISVSNLALACGNIGKEFAGVNPLRGQNNVQGACDMGALPSDY
PGYQKVFKPEIAEKFEAAWNAKLSREVGLTVSEMIQKAETGDLKFLYIMGENPMVSDPDINHVKHSLENI
DFLVVQDIFLTETAELADIVLPAASFAEKDGTFVNTERRVQRVRQAIPPVGGAKADWVILMELMNRLGYS
KTYGHPSEIMEEIAMVTPQYGGISYERIEKVGIQWPCPTADHPGTKYLHKAAIARGRGLFYPVEHTGSVE
TKDREYPFILTTGRILYHYHTRTMTGREEGLNKIVPNSYIEVNDITANKLDLEDGEVVKVSSRRGSIKVA
VKVTDIVDEDVVFIPFHFAQGAANYLTNAQHDPISKIPELKVAAVKLEKIV 
 
>SelD 
MNQNRRLTQMTKSAGUAAKLGPDVLAQVLCDLPKIEDPNLIVGLETSDDAAVYKINDDMALIQTLDFFTP
VVDDPYTYGQIAAANSLSDVYAMGGRPLTAMNIVCFPNCLDPKILNQILKGGADKVLESGALLVGGHTVE
DDEPKYGLSITGIVHPKKVWANSTAREGDYLILTKPVGLGVLNTAIKADIATKEQYDGAVKVMSMLNKYA
FEALENLDVSACTDITGFGFLGHVYEMAKGSGVSIEIFADKVPLIDGAKELATMGIIPAGMYSNKKHIEN
EVLKEQDIEDAIEDLLYDPQTSGGLLVSISEKDLPDALENLSLIESNGFSVVGRVLPRSDYAVYVK 
 
>GrdA 
MARFDGKKIIIIGDRDGIPGPAIEECLKGTGAEVVFSATECFVUTAAGAMDLENQQRVKDLTEKYGADNV
VVVLGAAEAEASGLAAETVTAGDPTFAGPLAGVQLGLRVYHAVEPQFKDEVDAGVYDDQVGMMEMVLDVD
SIVEEMNNIRSEFSKYND 
 
>GrdB 
MSKKRVVHYINQFFAGIGGEEKADIRPELREGVVGPGMALNTAMNEEAEIVATIICGDSYFNENLEEAKN
EIIEMVKKYNPDLFIAGPAFNAGRYGVACGTIAKAVNDELEIPVLTGMYIENPGADMFKKNIYIVETGNS
AAAMRKAVPAMASLAAKLLKGEAIGTPKEDQYIPRGIRKNYFSEEKGATRAVNMLMKKLKGEEFTTEYPM
PDFDRVDPNPAVQDLSKIKIAIVTSGGIVPKGNPERIESSSASKYGKYDISSFDDLTEADHETAHGGYDP
VYANIDPDRVIPVDVLRDMEKEGVIGELHKYFYTTVGNGTSVGNSKKFAEEFAKELIADGVQAVILTSTU
GTCTRCGATMVKEIERAGIPVVHMCTVVPISLTVGANRIVPTVAIPHPLGNPNLEPKEEKALRRKLVEKA
LEALTTEVAGQTVFE 
 
>Proline reductase 
MSLSIVKGLQSEIFVPITPPPVWTPVKKELKDMTIALATAAGVHLKSDKRFNLAGDFSFREVPVESLSTD
LMVSHGGYDNGDVNKDINCMFPIDRLKELAEEGFIKAAAPVHFGFMGGGGDQQKFQEETGPEIARRLKSE
GVDAVLLTAGUGTCHRSAVIVQRAIEESGIPTIIIAALPPVVRQNGTPRAVAPLVPMGANAGAPNDKAMQ
TAIVRDSLIQLVEITSAGKIVQLPYEYTAKV 
 
>HesB-like 
MKINLTESAKQEILKQNTKDRGVRIYVASMGUSGPSFSLSLEEATQHDVVKDVNGVKFVIDKMLDNRFDE
VKVDYGTVMFRKGFIVALENGGGGC 
 
>MsrA 
MDTNQKLSIAVFALGUFWGPDAQFGSIKGVVSTRVGYAGGTTNNPSYYNLGDHSESIEIQYDANVITYGE
LLNIFWNLHNPVYETTNRQYMSRIFYLDDGQKSEALEMKRQIEAANGEKIYTEIVPLENFYLAEGYHQKY
YLQNTTKLYQTLKAIYGGFGNLVRSTLAARMNGYIAGNLSIASLKEEMDLVELPEDQYEKVLSIVEEIK 
 
>Glutaredoxin 
MAKEVIVYTSNTUPHCFTVKEFLSENNVEFTEKNIQTDAAARKELMKKGIMAVPVIQIDEEVVVGFDRDK
IEELLG 
 
 2
 
#New 
>putative anaerobic dehydrogenase 
MKRRTFLKLSALTVGASALGLGITGCNKETDVSIDGFPEMPQTLGQGVEATVDPKSGEVKVNSDILVKSS
VCMGCYSSCGVRAKIDKQTGRIMKLTGNPYHPKCAEPALPYDTTIKESYQAFSLYGDQGHTHRATVCARG
NAAFEQVYDPMRITTPMKRAGERGSGKWKPISWEQLIEETVEGGKIFADLGDNTVVEGFRKVYSQDELIN
PDAPEMGPKSNGLVWISGGSYGRINFAQRFVLNSFGSTNFYGHTGTUGGAWRPAWQVLYDNGAGGVYKPD
LQDAEFCLYQGAYPGHSGMSFQTLARKTVKGVMENKLKLAVIDPFMQGGTDIPGKTKWIPIKPSTDGALV
LGMMRYIFDNEKFDGKFLECSNEEAAKAIGFKSYTNATHLVIVDEKHPNNRRFLKPEDLGLEGEGFFVID
KKTGKPELHSKASAGNLLYSGEIQGKTGTIKVATSLYLLKQGIERHSLEEYAEICGIPAKQIEELAKEFT
SHGHKVAVDTLGGTNSVNSLPFTVALWILPALMGAYNMKGGMAGNGPSFKAFADGPKYDLAAFEGQIKPS
GVKISREQFPYEKTTEYKNKVAQGKKPYPSKLPWHTNGMSLDGQAMFSALNKYPYQCKILVNCFANPLYG
TPSLYQETMLEELKKTSNIPLIISVDIVMGETTAYADYIVPDTSVYEQWAMVPVRANINTKMTAIRYPMI
EPMTPKVGSSNQPISMETYLIEVAKKIGMPGFGDNAIKDADGKLWPLNTREDYFIKAIANMAYDGEAVSS
ITEEDDKITGLDSIPSDWQAAIKPDELFVVKNVIAKGGRFEADTNYHDGQFMKYGDLVKVCFYSENLANS
RNSITGAYNEGSPVWAPETLADGTLVDQAYPSEEYPFRVCSSKAKLRGVSMLNNCPTLQVLSDTNYIEIN
ALDAKDFGLKDGQEVMVETPSNKAKGVLKVREGVARGSLGISFGYGKWEYGSKDTTIDGKVVKGESIRAV
GIASNPLALIDHSVKGKYGLSEVTSGTHNRNGIRAKIVPLS 
 
>BFD-like (2Fe-2S)-binding domain protein 
MEENIMNRNCUGSQANSTSLVEENKFCPICNEEGIQVKGITVKHMVIENLIPQVEDDNYYLCLSEKCDIV
YYSSNSDFHIEKEQIKVPIWFKEDANPKYICYCNRVTEENIVNAIRNEGARNIKDIIKLTGAMKNGKCEI
NHPTGKCCSPIIQETIDRALGI 
 
>Split soret cytochrome c precursor 1 
MAMEEKKQMTRKDFLKKAGMSVAGVAMAGGVGGILTACTNSGTASVNSTGTPDKPQWPFKYVKIDPAKAE
ARAYTGYKEKGGUGAGVAEGFFGTLADEAGYPFNQIPAEAFTAAAGGYGQATLCGSLGVAAACIGMVTDV
DTQKKIVGELFKWYKTAEFPQYQPEGLGLKHTVAESILCEDSVGTFMKEQGVAYGDPERKARCAGTAADV
TRKMVELLNETLA 
 
>Split soret cytochrome c precursor 2 
MDVKKSITRKDFLKRAGMSAAGIAMAGGVGGILTACTNAGTASVNSTGTPDKPQWPFKYVKLDPAKVEER
AFKGYKEKGGUGVGVAEGFFGTLADEVGYPFNQIPTEGFTAAAGGYGMATLCGSLGVAAACIGMVTDVDT
QKKIVADLYKWYKTFEFPQYQPEGLGLKHTVAESVLCEDSVGKFMKEQGVAYGDPERKSRCAGVTADVTR
KMVELLNEALA 
 
>COG4656: Predicted NADH:ubiquinone oxidoreductase, subunit RnfC 
MLIKISLKQHVGVESKAIVKENEKVKKGQLLAVPDGLGSNIHSSVHGIIEKVTSEYVSIKAYSDQSEDYM
MIKATDNYLEAIKEAGVVGAGGAGFPTHIKLDVDLTGGYVIVNAAECEPVLNHNMLAIEKQPDLILRGLK
YVMEITKAAKGYIAIKPKNKNAIIALGKVCKSESNIEIKFLPDMYPAGDERVIVRELLNVELKPGKLPIE
VNTVVLNIETIKNICLAIEKRKPVITKDITVGGRVKAPKVFLESPIGYPVSYFIDQCGGYENPHGEIVIG
GPFTGKKGGEETTIIKTTGGILVAMPFPVEKRKVGIIACECGAQEERLKEIAAGMEAEVVAEVQCKRMTA
FNGRYRCDLPGVCPGQAEKVLFLKKQGAEVIITGTCEDUTNTVMMTAPRLGVPVYHSTDHVLRGSNHKLY
RKKQ 
